Transparency Market
Research Reports incorporated a definite business overview and investigation
inclines on "Narcolepsy Marke ". This report likewise incorporates more
illumination about fundamental review of the business including definitions,
requisitions and worldwide business sector industry structure. Narcolepsy
is a chronic neurological disorder, which is characterized by brain’s inability
to control the sleep-wake cycle of an individual. This disorder is not caused
due to any mental illness, but is mainly caused due to genetic abnormalities
occurring from environmental factors or biologic factors.
Browse
Full Report with TOC:
Narcoleptic individuals
exhibita typical characteristic symptom, i.e. excessive daytime sleepiness
(EDS), where individuals experience disturbed night sleep and abnormal daytime
sleep pattern. Narcolepsy disorder is often confused with insomnia. Other major
symptoms of this disorder include, cataplexy, sleep paralysis, hypnagogic
hallucinations, automatic behavior and night weakness.
Some of the major
factors driving the growth of this market include increasing prevalence of
various sleep disorders including narcolepsy, rising awareness about the
disorder and increasing demand for advanced therapeutics and
diagnostics.Narcoleptic disorder is equally prevalent to Parkinson’s disease or
multiple sclerosis and is more prevalent than cystic fibrosis. There are more
than 3 million people suffering from this disorder worldwide.Rising awareness
about the disorder, and the resultant increase in demand for new and innovative
drugs and other treatment optionswill lead to the growth of this market in
future.
Geographically, North America dominates the global narcolepsy market followed by Europe. Major factors responsible for their dominance are high prevalence rate of narcolepsy in these regions. U.S. alone accounts for more than 200,000 narcoleptic individuals and is also characterized by high awareness levels among the general population. Asia-Pacific region exhibited fastest growth in this market due to increasing awareness levels about the disease and its treatment options and increasing spending power of the population.
Some of the key players operating in this market are Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
More
Reports on Pharmaceutical Market:
Browse Market Research Report:-
About Us:-
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insights
for thousands of decision-makers.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
0 comments:
Post a Comment